{"schema_version":"secwatch.filing_event.v1","accession":"0001689548-26-000072","form_type":"8-K","ticker":"PRAX","cik":"0001689548","company_name":"Praxis Precision Medicines, Inc.","filed_at":"2026-07-07T21:05:03+00:00","discovered_at":"2026-07-07T21:06:00.244288+00:00","generated_at":"2026-07-07T21:06:03.847524+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Praxis Precision Medicines partners with Remagine Labs for transdermal patch of ulixacaltamide","bullets":["Collaboration to develop iontophoretic transdermal patch for ulixacaltamide for essential tremor.","Remagine's platform enables precise, multi-day active transdermal dosing.","Praxis made an equity investment in Remagine to support program advancement.","Transdermal option intended to broaden patient population and strengthen competitive positioning."],"urls":{"canonical":"https://secwatch.observer/filing/0001689548-26-000072","json":"https://secwatch.observer/filing/0001689548-26-000072.json","markdown":"https://secwatch.observer/filing/0001689548-26-000072.md","text":"https://secwatch.observer/filing/0001689548-26-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000072/0001689548-26-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1689548/000168954826000072/prax-20260707.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T21:06:03.847524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}